1. Home
  2. VHI vs AURA Comparison

VHI vs AURA Comparison

Compare VHI & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VHI

Valhi Inc.

HOLD

Current Price

$15.87

Market Cap

370.5M

Sector

Industrials

ML Signal

HOLD

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

HOLD

Current Price

$5.70

Market Cap

357.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VHI
AURA
Founded
1932
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
370.5M
357.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
VHI
AURA
Price
$15.87
$5.70
Analyst Decision
Sell
Strong Buy
Analyst Count
1
5
Target Price
$12.00
$20.20
AVG Volume (30 Days)
32.7K
188.2K
Earning Date
03-10-2026
03-23-2026
Dividend Yield
2.05%
N/A
EPS Growth
N/A
N/A
EPS
0.65
N/A
Revenue
$2,063,400,000.00
N/A
Revenue This Year
$22.20
N/A
Revenue Next Year
$7.66
N/A
P/E Ratio
$24.21
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.44
$4.35
52 Week High
$20.39
$8.16

Technical Indicators

Market Signals
Indicator
VHI
AURA
Relative Strength Index (RSI) 59.98 49.76
Support Level $15.25 $5.26
Resistance Level $16.31 $5.82
Average True Range (ATR) 0.77 0.32
MACD 0.05 0.00
Stochastic Oscillator 75.25 34.83

Price Performance

Historical Comparison
VHI
AURA

About VHI Valhi Inc.

Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management services through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment, which produces and markets value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to various products, including paints, plastics, paper, fibers, and ceramics. Geographically, the company generates maximum revenue from the United States and also has a presence in Germany, Canada, Norway, and Belgium.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: